CFLT · As filed with the SEC
Confluent cash flow statement, by fiscal year
The statement as Confluent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | (295,275) | (345,065) | (442,746) | (452,551) |
| Adjustments to reconcile net loss to cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | 29,556 | 22,089 | 13,910 | 7,620 |
| Net accretion of discounts on marketable securities | (22,300) | (37,766) | (42,505) | (8,891) |
| Amortization of debt issuance costs | 3,839 | 3,836 | 3,813 | 3,799 |
| Amortization of deferred contract acquisition costs | 58,310 | 54,258 | 45,888 | 37,339 |
| Non-cash operating lease costs | 4,300 | 3,966 | 3,992 | 8,608 |
| Lease abandonment charges | 0 | 0 | 15,667 | — |
| Common stock charitable donation expense | — | — | 0 | 0 |
| Stock-based compensation, net of amounts capitalized | 397,325 | 395,660 | 349,833 | 277,656 |
| Deferred income taxes | — | 277,000 | 1,889,000 | (237,000) |
| Deferred income taxes | (18,699) | — | — | — |
| Other | 5,686 | 3,370 | 2,358 | 1,384 |
| Changes in operating assets and liabilities, net of effects of business combinations: | ||||
| Accounts receivable | (79,718) | (86,562) | (53,593) | (42,080) |
| Deferred contract acquisition costs | (71,853) | (53,246) | (61,354) | (62,801) |
| Prepaid expenses and other assets | (25,394) | 844 | (10,387) | (17,850) |
| Accounts payable | 13,466 | 127 | (14,452) | 13,580 |
| Accrued expenses and other liabilities | (15,512) | 25,639 | 61,333 | 9,948 |
| Operating lease liabilities | (8,894) | (10,140) | (7,479) | (9,209) |
| Deferred revenue | 89,437 | 56,173 | 30,176 | 76,352 |
| Net cash provided by (used in) operating activities | 64,274 | 33,460 | (103,657) | (157,333) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Capitalization of internal-use software costs | (22,558) | (21,404) | (17,845) | (10,334) |
| Purchases of marketable securities | (1,638,898) | (1,539,716) | (1,586,693) | (2,051,908) |
| Sales of marketable securities | 6,144 | 15,311 | — | 0 |
| Maturities of marketable securities | 1,474,654 | 1,591,164 | 1,578,323 | 1,200,558 |
| Purchases of investments in privately-held companies | (750) | (2,250) | — | — |
| Purchases of property and equipment | (3,597) | (2,567) | (2,834) | (4,121) |
| Cash paid for business combinations, net of cash acquired | 0 | (115,516) | (55,802) | — |
| Other | — | — | 0 | 0 |
| Net cash used in investing activities | (185,005) | (74,978) | (84,851) | (865,805) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Proceeds from initial public offering, net of underwriting discounts and commissions | — | — | 0 | 0 |
| Proceeds from issuance of common stock upon exercise of vested options | 57,260 | 55,836 | 73,919 | 42,461 |
| Proceeds from issuance of common stock upon early exercise of unvested options | — | 0 | 0 | 416,000 |
| Repurchases of unvested common stock | — | — | (255,000) | — |
| Payments of deferred offering costs | — | — | 0 | 0 |
| Proceeds from convertible senior notes, net of issuance costs | — | — | 0 | (786,000) |
| Payments for purchase of capped calls | — | — | 0 | 0 |
| Repurchases of unvested common stock | 0 | 0 | — | (789) |
| Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | — | — | — | 0 |
| Payments of debt issuance costs for convertible senior notes | — | 0 | — | — |
| Proceeds from issuance of common stock under employee stock purchase plan | 23,926 | 23,970 | 28,708 | 40,939 |
| Net cash provided by financing activities | 81,186 | 79,806 | 102,372 | 82,241 |
| Effect of exchange rate changes on cash and cash equivalents | — | (2,069,000) | 116,000 | (4,000) |
| Effect of exchange rate changes on cash and cash equivalents | 775 | — | — | — |
| Net (decrease) increase in cash and cash equivalents | (38,770) | 36,219 | (86,020) | (940,901) |
| Cash and cash equivalents at beginning of period | 385,980 | 349,761 | 435,781 | 1,376,682 |
| Cash and cash equivalents at end of period | 347,210 | 385,980 | 349,761 | 435,781 |
| Supplementary cash flow disclosures: | ||||
| Cash paid for: | ||||
| Income taxes | 15,711 | 11,706 | 8,053 | 5,529 |
| Non-cash investing and financing activities: | ||||
| Stock-based compensation capitalized as internal-use software costs | 16,623 | 19,891 | 17,943 | 7,544 |
| Issuance of common stock in connection with a business combination | 0 | 2,642 | — | — |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 0 | 2,722 | 0 | 998 |
| Property and equipment included in accounts payable and accrued expenses and other liabilities | — | — | — | 0 |
| Issuance of common stock upon exercise of vested options included in prepaid expenses and other current assets | — | — | 0 | 0 |
| Vesting of early exercised stock options | 126 | 1,215 | 2,834 | 11,467 |
| Conversion of convertible founder stock for Series E redeemable convertible preferred stock | — | — | — | 0 |
| Unpaid deferred offering costs | — | — | — | 0 |
| Convertible senior notes issuance costs included in accrued expenses and other liabilities | — | — | 0 | 0 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.